Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220017222 220014193 0 98 Disease modification (D) 2015-04-16 2015-04-19 Dasatinib 02 N 220029424 DASATINIB
220017223 220007617 1.58 140 Curative (C) 2013-11-18 2013-11-18 AML 18 TRIAL Y N 220029428 AML18 TRIAL
220017224 220007617 null null Disease modification (D) 2017-02-12 2017-02-12 Dasatinib 02 N 220029428 DASATINIB
220017225 220007619 1.56 74.4 Curative (C) 2017-10-03 2017-10-08 Alemtuz+Fludara+Melphalan RIC MUD Y null 220029439 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017226 220007621 0 72 Adjuvant (A) 2016-08-07 2016-08-07 Rituximab N N 220029442 RITUXIMAB
220017227 220017745 1.84 110 Curative (C) 2014-01-14 2014-01-15 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220029445 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017228 220007627 1.81 88.7 null 2016-11-13 2017-02-23 AML 18 TRIAL null N 220029453 AML18 TRIAL
220017229 220007629 1.66 64.9 Curative (C) 2013-12-24 2014-03-11 AML18 PILOT TRIAL N N 220029454 PILOT TRIAL
220017231 220007634 1.65 81.6 Curative (C) null 2016-06-30 AML 18 Pilot Trial N null 220029467 PILOT TRIAL
220017232 220014203 1.68 76 null 2015-10-18 2015-10-18 Rituximab N null 220029470 RITUXIMAB
220017233 220007641 1.68 66 Curative (C) 2013-04-07 2013-04-07 AML 18 TRIAL null N 220029478 AML18 TRIAL
220017234 220007643 null null Curative (C) 2017-08-15 2017-08-19 Dasatinib N N 220029485 DASATINIB
220017235 220014207 1.63 57.6 Curative (C) 2015-11-12 2015-11-20 Alemtuz+Fludara+Melphalan RIC MUD N N 220029493 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017237 220007648 1.61 57.8 Curative (C) 2013-07-04 2013-07-11 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220029500 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017238 220017750 1.7 63.3 Disease modification (D) 2017-11-27 2017-11-27 Dasatinib N N 220029506 DASATINIB
220017239 220007650 null 60.8 null 2013-12-12 2014-01-21 AML18 PILOT TRIAL 1 N 220029507 PILOT TRIAL
220017240 220020887 1.56 null Curative (C) 2013-11-15 2013-11-22 Alemtuz+Fludara+Melphalan RIC MUD N N 220029514 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017241 220007652 null 0 Curative (C) 2017-06-10 2017-06-10 Dasatinib 2 N 220029514 DASATINIB
220017242 220019737 1.71 85.6 Curative (C) 2017-04-28 2017-05-11 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 2 N 220029522 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017243 220007654 1.67 75 Curative (C) 2014-06-07 2014-06-12 Alemtuz+Fludara+Melphalan RIC MUD N N 220029523 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017244 220007654 1.62 76 Curative (C) 2016-07-19 2016-07-31 AML18 PILOT TRIAL Y N 220029523 PILOT TRIAL
220017245 220007656 1.76 null Curative (C) 2013-05-13 2013-05-13 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220029537 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017246 220007657 1.77 null Disease modification (D) 2015-04-27 2015-04-29 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 02 N 220029540 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017249 220007660 1.77 76.2 Disease modification (D) 2014-04-07 2014-04-07 Rituximab N N 220029568 RITUXIMAB
220017250 220007662 1.63 42.5 Curative (C) 2013-09-23 2013-09-24 AML 18 TRIAL 1 N 220029586 AML18 TRIAL
220017251 220017760 1.6 67.8 Curative (C) 2018-02-20 2018-02-20 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220029591 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017252 220007666 1.71 74.9 Curative (C) 2016-08-14 2016-08-14 Rituximab N N 220029599 RITUXIMAB
220017253 220007671 1.61 80.5 Curative (C) 2015-01-15 2015-03-03 AML18 PILOT TRIAL Y N 220029606 PILOT TRIAL
220017254 220017762 1.8 82.8 Curative (C) 2017-08-18 2017-08-18 AML 18 Pilot Trial N N 220029608 PILOT TRIAL
220017255 220014226 null 77 Adjuvant (A) 2015-03-25 2015-05-15 AML18 PILOT TRIAL 01 N 220029610 PILOT TRIAL
220017256 220017763 null 67 Palliative (P) 2018-09-21 2018-09-21 Dasatinib N N 220029612 DASATINIB
220017257 220017763 1.59 null Curative (C) null 2016-05-12 Rituximab N N 220029612 RITUXIMAB
220017259 220014228 1.88 null Curative (C) 2017-12-14 2017-12-16 Dasatinib 99 N 220029628 DASATINIB
220017260 220020891 1.64 52 Curative (C) 2018-02-03 2018-03-19 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220029630 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017261 220007683 1.88 null Palliative (P) 2014-11-18 2014-12-15 Dasatinib 02 N 220029636 DASATINIB
220017262 220017765 1.63 82.2 Disease modification (D) null 2015-06-25 Dasatinib N N 220029639 DASATINIB
220017263 220014231 1.54 55 Curative (C) 2018-12-29 2018-12-29 Alemtuz+Fludara+Melphalan RIC MUD N N 220029651 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017264 220007685 1.74 57 Curative (C) 2017-11-09 2017-11-20 Alemtuz+Fludara+Melphalan RIC MUD N N 220029660 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017265 220007686 1.71 null Curative (C) 2014-06-01 2014-06-22 Dasatinib N null 220029662 DASATINIB
220017266 220007689 0 69.9 Curative (C) 2013-09-04 2013-10-16 AML18 PILOT TRIAL N N 220029664 PILOT TRIAL
220017267 220019746 1.67 56 Curative (C) 2017-04-21 2017-04-28 Dasatinib 02 N 220029666 DASATINIB
220017268 220007690 1.73 111.2 Curative (C) 2013-09-21 2013-09-21 AML 18 TRIAL N N 220029667 AML18 TRIAL
220017269 220017769 null 0 null null 2014-09-14 Dasatinib 02 N 220029672 DASATINIB
220017271 220007698 1.6 63 Curative (C) 2017-06-24 2017-07-22 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220029688 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017272 220007705 1.78 null Curative (C) 2017-01-17 2017-01-17 Rituximab N null 220029704 RITUXIMAB
220017273 220020892 1.58 55.6 null 2017-09-01 2017-10-02 Alemtuz+Fludara+Melphalan RIC MUD null N 220029705 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017274 220021530 1.56 60.7 Not known (9) 2017-06-28 2017-06-28 Dasatinib N N 220029706 DASATINIB
220017275 220007708 1.6 51.5 Curative (C) 2013-04-12 2013-06-28 AML 18 Pilot Trial 1 N 220029714 PILOT TRIAL
220017276 220007708 1.64 77 Disease modification (D) 2014-08-13 2014-10-15 Rituximab 2 N 220029714 RITUXIMAB
220017278 220007711 1.7 88.9 Disease modification (D) 2014-02-08 2014-06-21 Dasatinib N Y 220029736 DASATINIB